Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis.
Mortensen, Deborah L
Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. [electronic resource] - Journal of clinical pharmacology Mar 2005 - 286-98 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0091-2700
10.1177/0091270004270260 doi
Adolescent
Adult
Aged
Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Humanized
Antigen-Antibody Reactions
CD11a Antigen--immunology
Down-Regulation
Female
Humans
Leukocyte Count
Male
Middle Aged
Psoriasis--blood
T-Lymphocytes--drug effects
Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. [electronic resource] - Journal of clinical pharmacology Mar 2005 - 286-98 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0091-2700
10.1177/0091270004270260 doi
Adolescent
Adult
Aged
Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Humanized
Antigen-Antibody Reactions
CD11a Antigen--immunology
Down-Regulation
Female
Humans
Leukocyte Count
Male
Middle Aged
Psoriasis--blood
T-Lymphocytes--drug effects